Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity

ClinicalTrials.gov ID: NCT02871635

Public ClinicalTrials.gov record NCT02871635. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 11:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Exploratory Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Primary Objective: The primary objective of this trial is to compare the clinical efficacy of BI 695501 with EU-approved Humira® in patients with active Crohn's disease (CD). Secondary Objectives: The secondary objectives of this trial are to compare the efficacy and safety of BI 695501 with EU-approved Humira® across the induction and maintenance phases.

Study identification

NCT ID
NCT02871635
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
147 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 27, 2016
Primary completion
Apr 29, 2019
Completion
May 12, 2019
Last update posted
Jun 3, 2020

2016 – 2019

United States locations

U.S. sites
19
U.S. states
10
U.S. cities
19
Facility City State ZIP Site status
Borland-Groover Clinic Jacksonville Florida 32256
Hope Clinical Research Kissimmee Florida 34741
Center for Advanced GI Maitland Florida 32751
Advance Medical Research Center Miami Florida 33155
Advanced Research Institute, Inc New Port Richey Florida 34653
Doctors Clinical Research East Point Georgia 30344
Southwest Gastroenterology Oak Lawn Illinois 60453
University of Kansas Medical Center Kansas City Kansas 66160-7702
MGG Group Co. Inc. / Chevy Chase Clinical Research, Chevy Chase Maryland 20815
Gastro Center of Maryland Columbia Maryland 21045
Healthcare Research Network Hazelwood Missouri 63042
Asheville Gastroenterology Associates, PA Asheville North Carolina 28801
Great Lakes Gastroenterology Research, LLC Mentor Ohio 44060
Gastroenterology Associates, PA Greenville South Carolina 29615
Houston Endoscopy and Research Center Houston Texas 77079
Biopharma Informatic, Inc, dba Research Consultants Katy Texas 77450
Sagact, Pllc San Antonio Texas 78229
Baylor Scott and White Healthcare Temple Texas 76508
Victoria Gastroenterology Victoria Texas 77904

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 73 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02871635, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 3, 2020 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02871635 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →